An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

The National Agency for the Control of AIDS has described information in sections of the media regarding the withdrawal of ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...

The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...

Dolutegravir is one of the most effective and safest HIV medicines and is used by millions of adults and adolescents living ...

The Elizabeth Glaser Pediatric AIDS Foundation said the latest cuts will deprive 350,000 people of HIV treatment.

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

In the fight against HIV, one of the most vulnerable populations is often overlooked - newborn babiesIt is estimated that 120,000 new HIV infections occur in children aged 14 years and younger every ...

South African researchers are making significant strides in validating traditional medicines for HIV treatment, highlighting the potential for economic growth and the integration of indigenous ...